BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 37084152)

  • 21. Response to neoadjuvant chemotherapy and survival in molecular subtypes of resectable gastric cancer: a post hoc analysis of the D1/D2 and CRITICS trials.
    Biesma HD; Soeratram TTD; Sikorska K; Caspers IA; van Essen HF; Egthuijsen JMP; Mookhoek A; van Laarhoven HWM; van Berge Henegouwen MI; Nordsmark M; van der Peet DL; Warmerdam FARM; Geenen MM; Loosveld OJL; Portielje JEA; Los M; Heideman DAM; Meershoek-Klein Kranenbarg E; Hartgrink HH; van Sandick J; Verheij M; van de Velde CJH; Cats A; Ylstra B; van Grieken NCT
    Gastric Cancer; 2022 May; 25(3):640-651. PubMed ID: 35129727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microsatellite instability and sex differences in resectable gastric cancer - A pooled analysis of three European cohorts.
    Quaas A; Biesma HD; Wagner AD; Verheij M; van Berge Henegouwen MI; Schoemig-Markiefka B; Pamuk A; Zander T; Siemanowski J; Sikorska K; Egthuijsen JMP; Meershoek-Klein Kranenbarg EM; van de Velde CJH; Buettner R; Alakus H; Cats A; Ylstra B; van Laarhoven HWM; van Grieken NCT
    Eur J Cancer; 2022 Sep; 173():95-104. PubMed ID: 35863110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pattern of recurrence and overall survival in esophagogastric cancer after perioperative FLOT and clinical outcomes in MSI-H population: the PROSECCO Study.
    Nappo F; Fornaro L; Pompella L; Catanese S; Lavacchi D; Spallanzani A; Cappetta A; Puzzoni M; Murgioni S; Barsotti G; Tirino G; Pellino A; Vivaldi C; Strippoli A; Aprile G; Di Donato S; Mazza E; Prisciandaro M; Antonuzzo L; Zagonel V; Cascinu S; De Vita F; Lonardi S
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):6601-6611. PubMed ID: 36795195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression Profile of Markers for Targeted Therapy in Gastric Cancer Patients: HER-2, Microsatellite Instability and PD-L1.
    Pereira MA; Ramos MFKP; Dias AR; Faraj SF; Ribeiro RRE; de Castria TB; Zilberstein B; Alves VAF; Ribeiro U; de Mello ES
    Mol Diagn Ther; 2019 Dec; 23(6):761-771. PubMed ID: 31595457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemosensitivity and survival in gastric cancer patients with microsatellite instability.
    Oki E; Kakeji Y; Zhao Y; Yoshida R; Ando K; Masuda T; Ohgaki K; Morita M; Maehara Y
    Ann Surg Oncol; 2009 Sep; 16(9):2510-5. PubMed ID: 19565284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Role of Microsatellite Instability in Positive Margin Gastric Cancer Patients.
    Polom K; Marrelli D; Smyth EC; Voglino C; Roviello G; Pascale V; Varas J; Vindigni C; Roviello F
    Surg Innov; 2018 Apr; 25(2):99-104. PubMed ID: 29303062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microsatellite instability in sporadic gastric cancer: its prognostic role and guidance for 5-FU based chemotherapy after R0 resection.
    An JY; Kim H; Cheong JH; Hyung WJ; Kim H; Noh SH
    Int J Cancer; 2012 Jul; 131(2):505-11. PubMed ID: 21898388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microsatellite instability is associated with a better prognosis for gastric cancer patients after curative surgery.
    Fang WL; Chang SC; Lan YT; Huang KH; Chen JH; Lo SS; Hsieh MC; Li AF; Wu CW; Chiou SH
    World J Surg; 2012 Sep; 36(9):2131-8. PubMed ID: 22669398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Impact of Microsatellite Instability in Asian Gastric Cancer Patients Enrolled in the ARTIST Trial.
    Miceli R; An J; Di Bartolomeo M; Morano F; Kim ST; Park SH; Choi MG; Lee JH; Raimondi A; Fucà G; Sohn TS; Bae JM; Kim S; Lim DH; Kang WK; Kim KM; Pietrantonio F; Lee J
    Oncology; 2019; 97(1):38-43. PubMed ID: 31048579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Influence of neoadjuvant chemotherapy on microsatellite instability in gastric carcinoma].
    Sun XW; Zhan YQ; Li W; Xu L; Li JT; Chen XJ; Zhang RH; Xu DZ
    Ai Zheng; 2006 Dec; 25(12):1493-6. PubMed ID: 17166373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of microsatellite instability in sporadic locally advanced rectal cancer following neoadjuvant radiotherapy.
    Du C; Zhao J; Xue W; Dou F; Gu J
    Histopathology; 2013 Apr; 62(5):723-30. PubMed ID: 23425253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ataxia-telangiectasia-mutated protein expression with microsatellite instability in gastric cancer as prognostic marker.
    Kim JW; Im SA; Kim MA; Cho HJ; Lee DW; Lee KH; Kim TY; Han SW; Oh DY; Lee HJ; Kim TY; Yang HK; Kim WH; Bang YJ
    Int J Cancer; 2014 Jan; 134(1):72-80. PubMed ID: 23649938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biomarker evaluation in radically resectable locally advanced gastric cancer treated with neoadjuvant chemotherapy: an evidence reappraisal.
    Gervaso L; Pellicori S; Cella CA; Bagnardi V; Lordick F; Fazio N
    Ther Adv Med Oncol; 2021; 13():17588359211029559. PubMed ID: 34484429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microsatellite Status Affects Tumor Response and Survival in Patients Undergoing Neoadjuvant Chemotherapy for Clinical Stage III Gastric Cancer.
    Cai Z; Rui W; Li S; Fingerhut A; Sun J; Ma J; Zang L; Zhu Z; Zheng M
    Front Oncol; 2020; 10():614785. PubMed ID: 33384963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synchronous metastatic gastric cancer-molecular background and clinical implications with special attention to mismatch repair deficiency.
    Polom K; Böger C; Smyth E; Marrelli D; Behrens HM; Marano L; Becker T; Lordick F; Röcken C; Roviello F
    Eur J Surg Oncol; 2018 May; 44(5):626-631. PubMed ID: 29545085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mismatch Repair Status of Gastric Cancer and Its Association with the Local and Systemic Immune Response.
    Shin SJ; Kim SY; Choi YY; Son T; Cheong JH; Hyung WJ; Noh SH; Park CG; Kim HI
    Oncologist; 2019 Sep; 24(9):e835-e844. PubMed ID: 30894409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A greater lymph node yield is required during pathological examination in microsatellite instability-high gastric cancer.
    Cai Z; Song H; Fingerhut A; Sun J; Ma J; Zhang L; Li S; Yu C; Zheng M; Zang L
    BMC Cancer; 2021 Mar; 21(1):319. PubMed ID: 33765970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastric cancer with microsatellite instability displays increased thymidylate synthase expression.
    Pereira MA; Dias AR; Ramos MFKP; Cardili L; Moraes RDR; Zilberstein B; Nahas SC; Mello ES; Ribeiro U
    J Surg Oncol; 2022 Jul; 126(1):116-124. PubMed ID: 35689583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strong Prognostic Value of Microsatellite Instability in Intestinal Type Non-cardia Gastric Cancer.
    Marrelli D; Polom K; Pascale V; Vindigni C; Piagnerelli R; De Franco L; Ferrara F; Roviello G; Garosi L; Petrioli R; Roviello F
    Ann Surg Oncol; 2016 Mar; 23(3):943-50. PubMed ID: 26530444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microsatellite Instability was not Associated with Survival in Stage III Colon Cancer Treated with Adjuvant Chemotherapy of Oxaliplatin and Infusional 5-Fluorouracil and Leucovorin (FOLFOX).
    Kim JE; Hong YS; Kim HJ; Kim KP; Kim SY; Lim SB; Park IJ; Kim CW; Yoon YS; Yu CS; Kim JC; Kim JH; Kim TW
    Ann Surg Oncol; 2017 May; 24(5):1289-1294. PubMed ID: 27853901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.